BKYIIndustrials · Security & Protection ServicesThe 1 Wall Street analysts covering BIO-key International, Inc. hold a median 12-month price target of $20 — +551.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 48 of 100 as at 22 Aug 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores BIO-key International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (97): Smaller than most of the companies we track.
Momentum (10): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on BKYI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +551.5% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 Mar 2021 | Maxim Group | Upgrade | Buy | $6.00 |
| 25 Nov 2020 | Maxim Group | Downgrade | Hold | — |
| 4 Oct 2019 | Maxim Group | Downgrade | Hold | — |
| 16 Aug 2018 | Maxim Group | Maintains | Buy | $5.50 → $5.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BKYI appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 79% of US stocks
Cheaper than 78% of US stocks
Cheaper than 79% of US stocks
Cheaper than 68% of US stocks
Higher than 59% of US stocks
Higher than 68% of US stocks
Higher than 92% of US stocks
Higher than 20% of US stocks
Higher than 6% of US stocks
Higher than 12% of US stocks
Higher than 17% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own BIO-key International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
BIO-key International held its Q2 2026 earnings call, and Seeking Alpha published a transcript of the event.
Why it matters — The earnings call transcript provides BKYI watchers with management's detailed discussion of the company's financial results and operational performance for the quarter.
BIO-key International reported a 13% rise in second-quarter revenues and a 51% improvement in its bottom line, driven by strength with government, defense, and financial sector customers globally. The company also announced an upcoming earnings call at 10am ET.
Why it matters — A BKYI watcher would care because the company's revenue growth and significantly improved bottom line suggest strengthening demand from key institutional sectors like government, defense, and finance.
The Portuguese national security agency has selected BIO-key (BKYI) and Visualforma to strengthen identity security, utilizing BIO-key's advanced identity and access management (IAM) and biometric authentication solutions.
Why it matters — This selection represents an adoption of BIO-key's IAM and biometric technology by a national government security agency, expanding its presence in the public sector.
BIO-key International announced it will host its Q2 2026 investor call and webcast on Friday, August 14th at 10 a.m. ET. The company is a global provider of Identity and Access Management and biometric authentication technologies.
Why it matters — Investors and followers of BIO-key can obtain updates on the company's second-quarter performance directly from management during the scheduled call and webcast.
BIO-key announced a partnership with Maktabi Tech to advance identity security across Saudi Arabia's education sector. The collaboration combines BIO-key's identity and access management (IAM) platform with Maktabi Tech's education market expertise, applying global best practices and regional knowledge to schools in Saudi Arabia.
Why it matters — For BKYI watchers, this signals the company expanding its identity management platform into Saudi Arabia's education market through a regional partner.
The 1 Wall Street analysts covering BIO-key International, Inc. have a median 12-month price target of $20, with estimates ranging from $20 to $20. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 1 analysts covering BIO-key International, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BIO-key International, Inc. 48 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 22 Aug 2026, BIO-key International, Inc. ranks 48 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (97 of 100).
No one can know that. What the data says: the median 12-month target from 1 analysts implies +551.5% from the last close, and Ticker Nerd's factor model ranks BIO-key International, Inc. 48 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering BIO-key International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BKYI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $20 to $20 over the next 12 months.
BIO-key International, Inc. returned -59.6% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Bio-key International Inc. is a provider of biometric identity and access management (IAM) solutions.
The most recent item we track (Seeking Alpha, 14 Aug 2026): "BIO-key International, Inc. (BKYI) Q2 2026 Earnings Call Transcript". BIO-key International held its Q2 2026 earnings call, and Seeking Alpha published a transcript of the event.
Bio-key International Inc. is a provider of biometric identity and access management (IAM) solutions. It develops and markets fingerprint biometric identification, identity verification technologies, and enterprise-ready software for secure authentication. Key products include PortalGuard IAM and IDaaS platforms, which offer passwordless multi-factor authentication (MFA), single sign-on, self-service password reset, and identity-bound biometrics that enable rapid, accurate user verification from large databases. These solutions support cloud, hybrid, and on-premises deployments with high feature parity, flexible integrations, and options for biometrics like SideSwipe and WEB-key. Bio-key International Inc. serves sectors including financial services, healthcare, education, government, manufacturing, transportation, and commercial enterprises, helping organizations secure workforces, students, and partner networks while addressing phishing risks and remote work challenges. Founded in 1993 and headquartered in the United States, it emphasizes affordable, customizable IAM to streamline access and enhance cybersecurity.
CEO Mr. Michael W. DePasquale · 41 employees · United States · https://www.bio-key.com